Neuroblastoma in a patient with the Beckwith-Wiedemann syndrome (BWS)

Medical and Pediatric Oncology

Volumn 38, Issue 3, 2002, Pages 193-199

  Coppes, Max J ^a   Yoon, Grace ^a   Graham, Gail ^a   Weksberg, Rosanna ^b   Gaul, H Penney ^c   DeBaun, Michael R ^d  

^a ALBERTA CHILDREN'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Pediatric Radiology   (Canada)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Beckwith Wiedeman syndrome; Childhood cancer; Neuroblastoma; Screening

Indexed keywords

BECKWITH WIEDEMANN SYNDROME; CANCER SCREENING; CASE REPORT; CHILD; CHILDHOOD CANCER; CHROMOSOME 11P; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DISEASE ASSOCIATION; FEMALE; HETEROZYGOSITY LOSS; HUMAN; NEUROBLASTOMA; PRIORITY JOURNAL;

ALBERTA; BECKWITH-WIEDEMANN SYNDROME; CHILD, PRESCHOOL; FEMALE; HUMANS; MASS SCREENING; MEDIASTINAL NEOPLASMS; NEUROBLASTOMA;

EID: 0036182470     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.1310     Document Type: Article

References (33)

1. Summary and recommendations of the workshop held at the first international conference on molecular and clinical genetics of childhood renal tumors, Albuquerque, New Mexico
2. Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas
3. Clinical phenotypes and Wilms tumor
4. Beckwith-Wiedemann syndrome. An update and review for the primary pediatrician
5. Recognition and management of childhood cancer syndromes: A systems approach
6. Neuroblastoma in a child with Wiedemann-Beckwith syndrome
7. Screening for Wilms' tumor in children with high-risk congenital syndromes: Considerations for an intervention trial
8. Use of the hazard rate to schedule follow-up exams efficiently
9. Screening for Wilms tumor in children with Beckwith-Wiedemann syndrom or idiopathic hemihypertrophy
10. Children at increased risk for Wilms tumor: Monitoring issues
11. Nephromegaly in infancy and early childhood: A risk factor for Wilms tumor in Beckwith-Wiedemann syndrome
12. Alpha-fetoprotein (AFP) levels in normal children
13. Serum alphafetoprotein levels in Beckwith-Wiedemann syndrome
14. Risk of cancer during the first four years of life in children from the Beckwith-Wiedemann Syndrome Registry
15. Biological aspects of neuroblastoma screening
16. Screening for neuroblastoma in infants younger than 1 year of age: Review of the first 30 years
17. Screening infants for neuroblastoma does not reduce the incidence of poorprognosis disease
18. Loss of imprinting of a paternally expressed transcript, with antisense orientation to KVLQT1, occurs frequently in Beckwith-Wiedemann syndrome and is independent of insulin-like growth factor II imprinting
19. Beckwith-Wiedemann syndrome: Imprinting in clusters revisited
20. Beckwith-Wiedemann syndrome and hemihypertrophy
21. Gametic imprinting in mammals
22. Mutation and cancer: A model for Wilms' tumor of the kidney
23. Genomic imprinting and human neoplasia
24. Genomic imprinting in tumours
25. Genomic imprinting and cancer
26. Loss of imprinting of human insulin-like growth factor II gene, IGF2, in acute myeloid leukemia
27. Relaxation of imprinting of human insulin-like growth factor II gene, IGF2, in sporadic breast carcinomas
28. Loss of imprinting and genetic alterations of the cyclin-dependent kinase inhibitor p57KIP2 gene in head and neck squamous cell carcinoma
29. Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15.5
30. Imprinting and expression of insulin-like growth factor-II and H19 in normal breast tissue and breast tumor
31. Relaxation of imprinted genes in human cancer
32. Epigenetic gene silencing in cancer
33. Tumors and hemihypertrophy associated with Wiedemann-Beckwith syndrome